MEDNAX Inc
NYSE:MD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6.77
16.08
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
MEDNAX Inc
Wall Street
Price Targets
MD Price Targets Summary
MEDNAX Inc
According to Wall Street analysts, the average 1-year price target for
MD
is 16.54 USD
with a low forecast of 15.15 USD and a high forecast of 18.9 USD.
MD Last Price Targets
MEDNAX Inc
The latest public price target was made on Oct 7, 2024 by
David MacDonald
from
Truist Financial
,
who expects
MD
stock to
drop by 4%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
David MacDonald
Truist Financial
|
13
USD
Downside 4% |
2 months ago
Oct 7, 2024
|
Pediatrix Medical price target raised to $13 from $10 at Truist
TheFly
|
Jack Slevin
Jefferies
|
14
USD
Upside 3% |
3 months ago
Sep 26, 2024
|
Jefferies Upgrades Pediatrix Medical Group (MD) to Buy
StreetInsider
|
|
David MacDonald
Truist Financial
|
10
USD
Downside 26% |
4 months ago
Aug 15, 2024
|
Pediatrix Medical Group (MD) PT Raised to $10 at Truist Securities
StreetInsider
|
Pito Chickering
Deutsche Bank
|
8
USD
Downside 41% |
6 months ago
Jun 7, 2024
|
Deutsche Bank Upgrades Pediatrix Medical Group (MD) to Hold
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MD's stock price target?
Price Target
16.54
USD
According to Wall Street analysts, the average 1-year price target for
MD
is 16.54 USD
with a low forecast of 15.15 USD and a high forecast of 18.9 USD.
What is MEDNAX Inc's Revenue forecast?
Projected CAGR
2%
For the last 8 years the
compound annual growth rate for
MEDNAX Inc's revenue is
-4%.
The projected
CAGR
for the next 4 years is
2%.
What is MEDNAX Inc's Operating Income forecast?
Projected CAGR
4%
For the last 8 years the
compound annual growth rate for
MEDNAX Inc's operating income is
-15%.
The projected
CAGR
for the next 4 years is
4%.
You don't have any saved screeners yet
